• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性高碳酸血症加重期的心房颤动

Atrial fibrillation in the acute, hypercapnic exacerbations of COPD.

作者信息

Terzano C, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A

机构信息

Respiratory Diseases Unit, School of Specialization in Respiratory Diseases, University of Rome "Sapienza", Policlinico Umberto I, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2908-17.

PMID:25339486
Abstract

OBJECTIVE

Chronic obstructive pulmonary disease (COPD) has been associated with a high frequency of arrhythmias. Atrial fibrillation (AF) is one of the most common arrhythmias and causes substantial morbidity and mortality. Emerging risk factors for the development of AF include a variety of breathing disorders like COPD. Few studies have analyzed the role of reduced lung function and respiratory acidosis in predicting AF. Aim of the current study was to investigate the role of hypercapnia, pulmonary systolic hypertension and lung function impairment in COPD patients, as risk factors for atrial fibrillation development.

PATIENTS ANDV METHODS

We evaluated a population of individuals consecutively hospitalized for COPD exacerbation and hypercapnic respiratory failure between January 2012 and January 2013; among them we selected a subgroup of patients presenting a paroxysmal episode of atrial fibrillation. All patients underwent pulmonary function tests, haemogasanalysis, electrocardiogram and transthoracic echocardiography.

RESULTS

Among the 193 subjects evaluated, 35 individuals with AF and COPD were enrolled in the study. Risk of new AF was higher in those subjects with lower FEV1 and higher PaCO2 values, also there was a significantly increased prevalence of AF in patients with higher value of Pulmonary Artery Systolic Pressure (PASP), obtained by transthoracic echocardiography. Linear correlation between variables revealed a direct relationships between hypercapnia and PASP and left and right atrial areas.

CONCLUSIONS

Impaired pulmonary function, hypercapnia and high values of PASP are independent predictors of incident AF.

摘要

目的

慢性阻塞性肺疾病(COPD)与心律失常的高发生率相关。心房颤动(AF)是最常见的心律失常之一,会导致严重的发病和死亡。AF发生的新出现的危险因素包括多种呼吸障碍,如COPD。很少有研究分析肺功能降低和呼吸性酸中毒在预测AF中的作用。本研究的目的是调查高碳酸血症、肺动脉收缩压和肺功能损害在COPD患者中作为心房颤动发生危险因素的作用。

患者和方法

我们评估了2012年1月至2013年1月期间因COPD急性加重和高碳酸血症呼吸衰竭而连续住院的人群;其中我们选择了出现阵发性心房颤动发作的患者亚组。所有患者均接受了肺功能测试、血气分析、心电图和经胸超声心动图检查。

结果

在评估的193名受试者中,35名患有AF和COPD的个体被纳入研究。FEV1较低和PaCO2值较高的受试者发生新发AF的风险更高,通过经胸超声心动图获得的肺动脉收缩压(PASP)值较高的患者中AF的患病率也显著增加。变量之间的线性相关性显示高碳酸血症与PASP以及左、右心房面积之间存在直接关系。

结论

肺功能受损、高碳酸血症和高PASP值是新发AF的独立预测因素。

相似文献

1
Atrial fibrillation in the acute, hypercapnic exacerbations of COPD.慢性阻塞性肺疾病急性高碳酸血症加重期的心房颤动
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2908-17.
2
Chronic obstructive pulmonary disease and the development of atrial fibrillation.慢性阻塞性肺疾病与心房颤动的发生。
Int J Cardiol. 2019 Feb 1;276:118-124. doi: 10.1016/j.ijcard.2018.09.056. Epub 2018 Sep 15.
3
Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension.无创通气治疗伴有肺动脉高压的慢性高碳酸血症 COPD 急性加重期患者。
Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):183-91.
4
Third dimension refines sensitivity.第三维提高了灵敏度。
Eur Rev Med Pharmacol Sci. 2015;19(2):184.
5
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.慢性阻塞性肺疾病对心房颤动预后的影响:欧洲观察性研究计划心房颤动试点调查(EORP-AF)总登记处的报告
Am Heart J. 2016 Nov;181:83-91. doi: 10.1016/j.ahj.2016.08.011. Epub 2016 Aug 27.
6
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.慢性阻塞性肺疾病合并心房颤动成人患者的特征及预后
Heart. 2018 Nov;104(22):1850-1858. doi: 10.1136/heartjnl-2017-312735. Epub 2018 Jun 6.
7
Competitive interaction between chronic obstructive pulmonary disease and CHADS-VASc score in predicting incident atrial fibrillation.慢性阻塞性肺疾病与 CHADS-VASc 评分在预测新发心房颤动中的竞争作用。
Int J Cardiol. 2018 Mar 15;255:74-79. doi: 10.1016/j.ijcard.2017.11.036. Epub 2017 Nov 20.
8
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.COPD 加重后 30 天内与非致命性心力衰竭和心房颤动或扑动相关的因素:一项嵌套病例对照研究。
BMC Pulm Med. 2024 May 4;24(1):221. doi: 10.1186/s12890-024-03035-4.
9
Potential Augmentation of the Risk of Ischemic Cerebrovascular Accident by Chronic Obstructive Pulmonary Disease in Patients with Atrial Fibrillation.慢性阻塞性肺疾病对心房颤动患者缺血性脑血管意外风险的潜在增加作用
J Stroke Cerebrovasc Dis. 2015 Aug;24(8):1893-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.034. Epub 2015 Jun 30.
10
Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry.慢性阻塞性肺疾病对心房颤动的不良影响:翁布里亚心房颤动登记研究的新见解。
Medicina (Kaunas). 2019 Jul 9;55(7):358. doi: 10.3390/medicina55070358.

引用本文的文献

1
Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?2型呼吸衰竭ICU患者中的心房颤动:哪些人有风险以及结局如何?
Diagnostics (Basel). 2025 Jun 25;15(13):1612. doi: 10.3390/diagnostics15131612.
2
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
3
The Intersection of Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Recent Insights in a Challenging Area.
慢性阻塞性肺疾病与心血管疾病的交集:对这一具有挑战性领域的最新见解
CJC Open. 2025 Jan 8;7(4):493-507. doi: 10.1016/j.cjco.2025.01.001. eCollection 2025 Apr.
4
Gender-Based Differences in COPD Patients with Type 2 Respiratory Failure-Impact on Clinical Practice.2型呼吸衰竭慢性阻塞性肺疾病患者的性别差异——对临床实践的影响
Medicina (Kaunas). 2025 Mar 25;61(4):587. doi: 10.3390/medicina61040587.
5
Structured Cardiac Assessment and Treatment Following Exacerbations of COPD (SCATECOPD): A Pilot Randomised Controlled Trial.慢性阻塞性肺疾病急性加重后结构化心脏评估与治疗(SCATECOPD):一项试点随机对照试验
Biomedicines. 2025 Mar 7;13(3):658. doi: 10.3390/biomedicines13030658.
6
Outcomes in Atrial Fibrillation Patients with Different Clinical Phenotypes: Insights from the French Population.不同临床表型的心房颤动患者的结局:来自法国人群的见解
J Clin Med. 2025 Feb 7;14(4):1044. doi: 10.3390/jcm14041044.
7
Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case-control study.老年髋部骨折患者围手术期心房颤动的预测因素及预后:一项巢式病例对照研究。
BMC Geriatr. 2025 Jan 3;25(1):4. doi: 10.1186/s12877-024-05647-1.
8
Association of Atrial Fibrillation with Insomnia in the Elderly Population.心房颤动与老年人群失眠的关系。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241296623. doi: 10.1177/21501319241296623.
9
Bidirectional Causal Association Between Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: A Mendelian Randomization Study.慢性阻塞性肺疾病与心血管疾病之间的双向因果关系:一项孟德尔随机化研究。
Int J Chron Obstruct Pulmon Dis. 2024 Sep 25;19:2109-2122. doi: 10.2147/COPD.S475481. eCollection 2024.
10
Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.心房颤动的多学科治疗方法:堪比黄金。
J Clin Med. 2024 Aug 7;13(16):4621. doi: 10.3390/jcm13164621.